Antibodies against AILIM (also called ICOS and 8F4) were foundto significantly suppress the onset of inflammatory bowel diseases(especially Crohn's disease and colitis (ulcerative colitis andsuch)), and exhibit a significant therapeutic effect againstinflammatory bowel diseases.